The company announced the board meet before market hours today, 8 February 2010.

Meanwhile, the BSE Sensex was up 88.03 points, or 0.55% to 16,003.68.

On BSE, 45,524 shares were traded in the counter as against an average daily volume of 6,878 shares in the past one quarter.

The stock hit a high of Rs 213.10 and a low of Rs 185 so far during the day. The stock had hit a lifetime high of Rs 227 on 20 January 2010 and a 52-week low of Rs 33.15 on 27 March 2009.

The small-cap stock had outperformed the market over the past one month till 6 February 2010, rising 19.62% as compared to the Sensex's 10.09% fall. It had also outperformed the market in the past one quarter, gaining 34.16% as compared to the Sensex's decline of 1.50%.

The company's equity capital is Rs 5.51 crore. Face value per share is Rs 10.

The current price of Rs 211.05 discounts the company's Q3 December 2009 annualized EPS of Rs 32.45, by a PE multiple of 6.50.

If approved by the board, this will be a maiden bonus issue by Poly Medicure.

Poly Medicure's net profit jumped 587.7% to Rs 4.47 crore on 22.4% increase in net sales to Rs 33.97 crore in Q3 December 2009 over Q3 December 2008.

The company is engaged in manufacturing of disposable blood bags, IV cannula, endotracheal tubes, cold therapy pads and common disposables.